Dead-end pages

The following pages do not link to other pages in LipidomicsWiki.

Showing below up to 320 results starting with #1.

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)

1. 1st Annual LipidomicNet Steering intern
2. ABC transporter
3. ACAT in vitro assay
4. Absorption and lipoprotein transport of sphingomyelin
5. Acid ceramidase assay
6. AdditionalGroups
7. Adipocyte and SVF isolation from mouse adipose tissue
8. Adipocyte isolation and cultivation
9. Affymetrix SPP
10. Agilent not mapped probes
11. Alternative bile acid biosynthetic (acidic or sterol 27-hydroxylas) pathway
12. Aminoallyl Labeling of RNA for Microarray Hybridization
13. Analysis of lipid metabolism kinetics by pulse-chase in living cells (Thiele lab)
14. Antibodies against lipid droplet proteins
15. Antibodies from DeMatteis lab
16. ApoA-I containing lipoproteins
17. ApoB containing lipoproteins
18. Austria
19. Available Data
20. Bile acid homeostasis an Introduction
21. Bile acid regulation of drug metabolism
22. Bile acid regulation of glucose metabolism
23. Bile acid regulation of lipid metabolism
24. Bile acids/-conjugates determination - Perwaiz et al.
25. Bile acids/-conjugates determination - Tagliacozzi et al.
26. Bile acids/-conjugates determination - Von Eckardstein
27. Bile acids - LC-MS/MS - Scherer et al.
28. BioUML
29. Butanolic lipid extraction
30. CAR
31. CDP-Glycerols (GP13)
32. Cardiovascular diseases
33. Cell culture from DeMatteis lab
34. Cell isolation procedures
35. Cell proliferation BrdU (JUMC)
36. Ceramide Profiling LC-MS/MS
37. Ceramides - stratum corneum, free extractable - LC-MS - Farwanah et al.
38. Cholesterol biosynthesis assay
39. Cholesteroylation
40. Cholesteryl ester synthesis assay
41. Contact
42. Cytotoxicity assay (JUMC)
43. DNA constructs from DeMatteis lab
44. Data types and attributes in lipid species databases
45. Databases for lipid species
46. Davies et al.
47. Deliverables
48. Description of MS methods in databases
49. Description of samples in databases
50. Di-glycerol tetraether phospholipids (caldarchaeols) (GP18)
51. Docosanoids (FA04)
52. Document:From SDS to Integromics software.doc
53. Downloads
54. Eicosanoid determination - Harkewitz et al.
55. Eicosanoid determination - Masoodi et al.
56. Eicosanoid determination - Yue et al.
57. Erythrocyte isolation
58. Exchange Grants
59. Extension:Navigation path
60. Extensions LS/myCSS.css
61. FAQ
62. FAS II
63. FATP
64. FXR
65. FXR, LXRα, and PPAR regulation of triglyceride metabolism
66. FXR and LXRα regulation of lipoprotein metabolism
67. FXR regulation of bile acid synthesis, transport and absorption
68. Fatty Acid Profiling GC-MS
69. Fatty Acyls analysis by mass spectrometry
70. Fatty acid metabolism
71. Fatty acid oxidative conversion
72. Fatty acid remodelling
73. Filipin staining of cells
74. Finland
75. Fixation and permeabilization protocols from DeMAtteis lab
76. Fixation of cells with 4% paraformaldehyde
77. Fixed/permeabilized cultured cells - BD Pathway Bioimager 855 (JUMC)
78. Flow cytometry
79. Fluorescence Microscopy (High-Content Imaging) SPP for the analysis of lipid droplets for the Discovery-1 automated microscope of Molecular Devices
80. Fluorescent microscopy of neutral lipids in yeast
81. Free cholesterol/cholesterol ester distribution
82. Freeze Fracture
83. Funding for researchers
84. G-Protein Receptors lipid binding 20110810
85. GENE LIST Glycerophospholipid metabolism
86. Ganglioside extraction
87. Germany
88. Glycerol-nonitol tetraether phospholipids (GP19)
89. Glycerolipid Profiling - FT-MS
90. Glycerophosphatidylinositol (GPI)-anchor
91. Glycerophosphatidylinositol (GPI)-anchor biosynthesis
92. Glycerophosphoglycerophosphates (GP05)
93. Glycerophosphoglycerophosphoglycerols (GP12)
94. Glycerophosphoinositolglycans (GP15)
95. Glycerophosphoinositols (GP06) / phosphates (GP07-09)
96. Glycerophospholipid Profiling - FT-MS
97. Glycerophospholipid Profiling - LC-MS/MS
98. Glycerophosphonocholines (GP16)
99. Glycerophosphonoethanolamines (GP17)
100. Glyceropyrophosphates (GP11)
101. Glycosphingolipid biosynthesis
102. Glycosphingolipid degradation
103. Glycosphingolipid metabolism
104. Glycosylglycerophospholipids (GP14)
105. Granulocyte-enrichment
106. HF diet for mouse feeding
107. HMG-CoA reductase assay
108. HNF
109. HTP Image analysis of LD size in differentiated adipocytes
110. HUVEC isolation and cloning (JUMC)
111. Handling Synopsis Lists
112. Haschke et al.
113. Hepatocyte and Stellate cell isolation from mouse liver
114. High pressure freezing and freeze substitution of cells grown on Aclar discs (Burger lab)
115. Hybridization of labeled RNA to cDNA Microarrays
116. Images acquisition and analysis from De Matteis laboratory
117. Imaging of lipid droplets, nuclei and cytoplasm in the 96-well format (Thiele lab)
118. Immunofluorescence and Bodipy staining of lipid droplets
119. Implementation of High-Content Imaging SPPs
120. In vivo cell monitoring - BD Pathway Bioimager 855 (JUMC)
121. Inositol phosphates
122. Isolation of lipid droplets from mouse primary hepatocytes
123. Isolation of primary hepatocytes from mouse liver
124. Isoprostanes
125. Kick off meeting - June 2008
126. LXR
127. Leukocyte populations and platelets
128. Links
129. Lipases and LCAT
130. Lipid Conference Calendar
131. Lipid Storage Genes
132. Lipid extraction according to Bligh and Dyer
133. Lipid extraction according to Folch
134. Lipid extraction according to modified Folch
135. Lipid extraction for TLC (Chloroform-Methanol, Thiele lab)
136. Lipid extraction using Butanol
137. Lipid extraction using MTBE
138. Lipid microdomains
139. Lipid probes
140. LipidomicNet-ENOR joint workshop
141. LipidomicNet-ENOR workshop program
142. LipidomicNet Final Meeting - 10/2012
143. LipidomicNet Library
144. Lipoprotein preparation
145. Lipoprotein separation by FPLC - Wiesner et al.
146. Lipoprotein sphingolipids as potential atherogenic factors
147. Lysophospholipids
148. Lysosomal lipid-binding proteins: purification
149. Lysosomal storage disorders
150. MT 01.10.2008
151. MT 02.07.2008
152. MT 03.03.2010
153. MT 03.09.2008
154. MT 03.12.2008
155. MT 05.11.2008
156. MT 06.08.2008
157. MT 08.10.2008
158. MT 09.07.2008
159. MT 10.09.2008
160. MT 10.11.2008
161. MT 10.12.2008
162. MT 13.08.2008
163. MT 14.01.2009
164. MT 15.06.2008
165. MT 15.10.2008
166. MT 16.07.2008
167. MT 17.09.2008
168. MT 17.12.2008
169. MT 19.11.2008
170. MT 20.08.2008
171. MT 21.01.2009
172. MT 22.10.2008
173. MT 23.07.2008
174. MT 24.09.2008
175. MT 24.12.2008
176. MT 25.06.2008
177. MT 26.11.2008
178. MT 27.08.2008
179. MT 29.10.2008
180. MT 30.07.2008
181. Magnetic bead isolation of Mitochondria and following western blot analysis
182. Mass spectrometry
183. Mechanisms of bile acid feedback inhibition of gene transcription
184. Megakaryocyte Platelet Synopsis
185. Membranes
186. Metabolic diseases
187. Monoacylglycerophospholipids
188. Monocyte Isolation
189. Monoradylglycerols
190. Mouse Key Nodes
191. Netherlands
192. Non targeted Lipid Profiling LC-FT-MS/MS
193. Nuclear receptor regulation of bile acid synthesis
194. Nuclear receptors
195. Offline nanoESI Phospholipid Profiling - LC-MS/MS
196. Other hydroxylase pathways
197. Oxidized glycerophospholipids (GP20)
198. Oxysterol-binding proteins
199. Oxysterol binding assay
200. PRP-platelet rich plasma
201. PXR/SXR
202. Palmitoylation
203. Phosphatidylinositol metabolism
204. Phospholipid and neutral lipid droplet staining
205. Phospholipidosis detection
206. Plant sterols
207. Polyketides
208. Prenol Lipids
209. Prenylation
210. Preparation of delipidated FCS (Thiele lab)
211. Press releases
212. Project Status Report for Period 1
213. Project Status Report for Period 2
214. Proposal for lipid MS nomenclature
215. Prostaglandin quantification - GC-MS
216. Protocols for stable isotope labeling
217. Purification LDs from mouse adipocytes
218. Purification LDs from mouse hepatocytes
219. Quinones and hydroquinones
220. ROR
221. Real time interaction between immobilized liposomes and lipid binding proteins by Surface Plasmon Resonance
222. Regensburg2014
223. Regensburg Chip Hybridization Center
224. Retinoid determination - Gunderson et al.
225. Retinoid determination - Kane et al.
226. Retinoid determination - Wang et al.
227. SHP-dependent mechanism
228. SHP-independent mechanisms
229. SVF human cells isolation and culture (JUMC)
230. Schwedhelm et al.
231. Shorthand notation - General rules
232. Shorthand notation for Fatty Acyls (FA)
233. Shorthand notation for Glycerolipids (GL)
234. Shorthand notation for Glycerophospholipids (GP)
235. Shorthand notation for Sphingolipids (SP)
236. Shorthand notation for Sterols (ST)
237. SiRNA knock down - A431 cells - 24 well plate - biochemical analysis (Thiele lab)
238. SiRNA knock down - HeLa cells - 24 well plate - biochemical analysis (Thiele lab)
239. SiRNA knock down - HuH7 cells - 24 well plate - biochemical analysis (Thiele lab)
240. Signalling pathways induced by sphingolipids
241. Sircar et al.
242. Skin lipid analysis - HPTLC - Farwanah et al.
243. Sphingolipids and apoptosis
244. Sphingolipids and cell differentiation
245. Sphingolipids and cell migration and adhesion
246. Sphingolipids and vascular tone regulation
247. Sphingosine-1-phosphate - LC-MS/MS - Berdyshev et al.
248. Sphingosine-1-phosphate - LC-MS/MS - Bielawski et al.
249. Sphingosine-1-phosphate - LC-MS/MS - Schmidt et al.
250. Sphingosine-1-phosphate quantitation
251. Staining of cells
252. Staining of lipid droplets with Nile red and BODIPY 493/503
253. Staining of lipid droplets with oil Red O
254. Steering Committee Meeting - 01/2010
255. Steering Committee Meeting - 01/2011
256. Steering Committee Meeting - 01/2012
257. Steering Committee Meeting - 07/2009
258. Steering Committee Meeting - 07/2010
259. Steering Committee Meeting 2011/06
260. Sterols
261. Sterols (ST) determination - Lembcke et al.
262. Sterols (ST) determination - Mezine et al.
263. Subcategory: Monoacylglycerophospholipids
264. Synthesis and metabolism of straight chain fatty acids
265. TF IV 02.09.2008
266. TF IV 05.08.2008
267. TF IV 09.12.2008
268. TF IV 11.11.2008
269. TF IV 14.10.2008
270. TF IV 16.09.2008
271. TF IV 19.08.2008
272. TF IV 20.01.2009
273. TF IV 23.12.2008
274. TF IV 25.11.2008
275. TF IV 28.10.2008
276. TF IV 30.09.2008
277. TF I 21.10.2008
278. TF VIII 13.08.2008
279. TF VIII 30.07.2008
280. TF VIII ActionPoints 2010
281. TF VII 01.10.2008
282. TF VII 03.09.2008
283. TF VII 06.08.2008
284. TF VII 10.12.2008
285. TF VII 12.11.2008
286. TF VII 15.10.2008
287. TF VII 17.09.2008
288. TF VII 20.08.2008
289. TF VII 24.12.2008
290. TF VII 26.11.2008
291. TF VII 29.10.2008
292. TIC 2013 Tbilisi International Conference 2013
293. Tagged constructs of lipid droplet proteins for imaging
294. TaqMan Arrays
295. Task Force VIII phone conferences
296. Templates for presentations
297. Teststartpage
298. Teunissen et al.
299. The classic bile acid biosynthetic (neutral) pathway
300. Thin layer chromatography (Thiele Lab)
301. Thromboxanes (FA0303)
302. Tools
303. Total Lipid Profiling LTQ-FT
304. Transferproteins – CETP, PLTP
305. Triglyceride hydrolysis kinetics
306. UK
307. Uptake of glycerophospholipid precursors and the interconversion of glycerophospholipid species
308. Visualization of fixed/permeabilized cultured cells (JUMC)
309. WP III TF V 05.09.2008
310. WP III TF V 14.10.2008
311. WP III TF V 25.11.2008
312. Webex
313. Western blot of membrane proteins
314. Wiki Roadmap
315. Wikipedia:tutorial
316. Workshop - 2009/03
317. Workshop - 2009/10 - Abstracts
318. Workshop - 2010/04
319. Workshop - 2011/05
320. Workshop - 2012/07

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)